|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
10 October 2018 |
|
Main ID: |
ChiCTR1800018637 |
|
Date of registration:
|
2018-09-30 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Correlation between Human epididymis protein 4 and interstitial lung disease in patients with rheumatoid arthritis
|
|
Scientific title:
|
Correlation between Human epididymis protein 4 and interstitial lung disease in patients with rheumatoid arthritis |
|
Date of first enrolment:
|
2018-09-26 |
|
Target sample size:
|
Target condition:150;Difficult condition:100 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=31452 |
|
Study type:
|
Diagnostic test |
|
Study design:
|
Diagnostic test: case-control
|
|
Phase:
|
Diagnostic New Technique Clincal Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Fan Quming
|
|
Address:
|
63 Wenhua Road, Nanchong, Sichuan, China
63700
|
|
Telephone:
|
+86 13550592716 |
|
Email:
|
fanqum@163.com |
|
Affiliation:
|
Affiliated Hospital of North Sichuan Medical College |
|
|
Name:
|
Fan Quming
|
|
Address:
|
63 Wenhua Road, Nanchong, Sichuan, China
637000
|
|
Telephone:
|
+86 13550592716 |
|
Email:
|
fanqum@163.com |
|
Affiliation:
|
Affiliated Hospital of North Sichuan Medical College |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: (1) the diagnosis of RA in line with the 2010 American rheumatism association (ACR) for RA classification criteria;
(2) perfect the relevant inspection, a complete medical records.The cases were divided into 2 groups, group by: referring to the 2000 ATS diagnostic criteria, proposed ILD will chest high-resolution CT findings of nodules, patchy shadow, changes in a funicular, pleural thickening and pulmonary fibrosis patients classified as group with pulmonary interstitial change group.the rest is non-pulmonary parenchymal changes RA group.
Exclusion criteria: (1) with other connective tissue diseases;
(2) in chronic kidney disease;
(3) there are serious pulmonary infection, pulmonary tuberculosis, lung cancer and other lung diseases;
(4) ovarian cancer, endometrial cancer and other gynecological malignant tumors.
Age minimum:
Age maximum:
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
rheumatoid arthritis
|
|
Intervention(s)
|
|
Gold Standard:Clinical outcome, meet the 2010 ACR/EULAR rheumatoid arthritis classification criteria.;Index test:Human epididymis protein 4,anti-cyclic citrullinated peptide, creatinine, rheumatoid factor;
|
|
Primary Outcome(s)
|
|
Human epididymis protein 4;Imaging indicators of pulmonary fibrosis;creatinine;
|
|
Secondary Outcome(s)
|
|
anti-cyclic citrullinated peptide;rheumatoid factor;DAS28;
|
|
Source(s) of Monetary Support
|
|
Lateral project funding?,national sci-tech support plan
|
|
Ethics review
|
Status: Approved
Approval date: 29/03/2018
Contact:
Huang Meijie
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|